ASTMH Annual Meeting

13-17 Nov 2024
New Orleans, Louisiana, USA

The ASTMH Annual Meeting is the premier international forum for the exchange of scientific and clinical advances in tropical medicine, hygiene and global health. World-class research findings, clinical updates and topical discussions about the hot-button global issues from the world’s brightest scientific experts and thought leaders are presented over five days.

The scientific program is designed for researchers, professors, government and public health officials, military personnel, travel clinic physicians, practicing physicians in tropical medicine, students, and all healthcare providers working in the fields of tropical medicine, hygiene, and global health. The meeting draws thousands of tropical medicine and global health professionals representing academia, foundations, government, not-for-profit organizations, non-governmental organizations, the private sector, the military, and private practice.

Find out more here.

FIND BELOW ALL SCHISTOSOMIASIS RELATED SESSIONS

 

Wednesday, Nov 13

8412 - Association of S. haematobium Infection with Pregnancy in Tanzania - Young Investigator Award Session E

Convention Center - Room 354/355 (3rd Floor) 9:00 AM

Thursday, Nov 14

POSTER SESSION A

Convention Center - Hall I-1 (1st Floor) 28 - Poster Session A - 12:00 PM

LB-9022 - Two-stage juvenile-adult model of Schistosomiasis and its implications for disease transmission, persistence, breakpoints and control outcomes

LB-9135 - Implementation of the Schistosomiasis Practical and Precision Assessment guidance for assessment of the impact of mass drug administration on schistosomiasis in five districts of Tanzania

6667 - Risk factors and ultrasound aspects associated with Urogenital Schistosomiasis among primary school children in Mali West Africa

6673 - Monitoring the impact of Community-based deworming on Schistosomiasis and Soil-transmitted helminthiasis among school-age children in western Kenya: Midterm resullts

6679 - A Follow-Up Study in 2024: Schistosomiasis Impact Assessment in Eight Districts Following a Decade of Mass Drug Administration

6718 - Identifying platforms for optimal delivery of a novel pediatric praziquantel formulation for schistosomiasis treatment in hard-to-reach areas and populations in Kenya - What are the key contextual factors?

6723 - Detection of Schistosoma haematobium cell-free DNA in urine samples stored on filter papers to improve the diagnostic of urinary schistosomiasis

6724 - Factors influencing the resolution of female genital schistosomiasis: a longitudinal study from rural Madagascar

6725 - Accurate Detection of Female Genital Schistosomiasis - A Neglected Gynecological Tropical Disease

6727 - Enhancing detection and monitoring of schistosomiasis using Flow, a urine-based analyte pre-concentration technology

6728 - Risk Factors for Schistosomiasis Cure Failure/Reinfection Among Pre-School-Aged Children 12 Months after treatment in Uganda

6730 - Novel Intervention Strategies for Schistosomiasis Elimination

6735 - Suitable Communication Strategies Prior to the Introduction of a Novel Pediatric Treatment Option < Schistosomiasis in Kenya

 


36 - American Committee on Clinical Tropical Medicine and Travelers' Health (Clinical Group - ACCTMTH) Symposium I: Vincenzo Marcolongo Lecture: Schistosomiasis: Insights Into Immunology and Treatment from Human Challenge Studies

Convention Center - Room 352 (3rd Floor) -  3:00 PM


37 - American Committee of Molecular Cellular and Immunoparasitology (ASMCIP): Molecular Approaches to Parasite Infection, Growth and Development

Concention Center - Room 353 (3rd Floor) - 3:00 PM

  • 3:30 PM - Genome-wide association study of an African snail vector of schistosomiasis identifies genes associated with resistance to infection by Schistosoma mansoni - Michelle Steinauer

48 - Water, Sanitation, Hygiene and Environmental Health (WaSH-E): Outcomes

Convention Center - Room 345 (3rd Floor) - 5:15 PM

  • 6:45 PM - Community perceptions of open defecation and schistosomiasis control: Lessons learned from a rapid ethnographic assessment study in three endemic lakeshore communities in Mayuge, Uganda - Poppy Lamberton

 

 

Friday, Nov 15

67 - Schistosomiasis and Pre-School Age Children: Burden, Morbidity, and Update on Treatment Approaches

Convention Center - Room 354/355 (3rd Floor)

  • 10:25 AM Prevalence and morbidity due to schistosomiasis among pre school age children and burden of anemia due to schistosomiasis in this age group - Susannah Colt
  • 10:40 AM Impact of varying Praziquantel doses (20, 40, 60 mg/kg) on safety and efficacy for the treatment of schistosomiasis - Jean Coulibaly
  • 10:55 AM Orodispersible Arpraziquantel development and next steps - Rana Afshar
  • 11:10 AM Needs and Gaps in Treatment for Schistosomiasis Among Preschool Aged Children - Prudence Beinamaryo
  • 11:25 AM Impact of 40 vs 60 mg/kg of Praziquantel on cure rate, egg reduction rate, and morbidity among pre school aged children in Uganda - Amaya Bustinduy

71 - Working Together: How NTD Elimination and Maternal Health Programs Can Learn and Collaborate to Decrease Disease and Maternal Mortality

Convention Center - Room 388/389 (3rd Floor) 10:15 AM

  • 11:05AM - Updates on the Intersection of Sexual and Reproductive Health and Rights (SRHR) and Tropical Diseases; highlights on Congenital Chagas and Female Genital Schistosomiasis (FGS)

86 - Measures for Control and Elimination of Neglected Tropical Diseases

Convention Center Room - 357 (3rd Floor) - 1:45 PM

  • 2:15 PM Factors influencing the uptake of mass drug administration for schistosomiasis among preschool-aged children: a cross-sectional study from Madagascar - Valentina Marchese
  • 2:30 PM Exploring the relationship between WASH (Water, Sanitation, and Hygiene) Access in schools and schistosomiasis prevalence - Victoria Turay
  • 2:45 PM Modeling the impact of improved water, sanitation and hygiene conditions due to the coronavirus disease prevention measures on soil-transmitted helminthiasis and schistosomiasis infections in Kenya: What lessons can we learn from this natural experiment? - Collins Okoyo

100 - Innovative Local Solutions and Novel Data Use Toward Last Mile Efforts in Eliminating Neglected Tropical Diseases

Convention Center - Room 388/389 (3rd Floor) - 4:00 PM

  • 4:10 PM A digital platform for monitoring the implementation of PC-NTD interventions: the ESPEN IU Planner - Jorge Cano
  • 5:10 PM Sub-district MDA data collection and analysis integrated with the supervisors’ coverage tool for improved program implementation - Victoria Turay
  • 5:30 PM Unravelling the mystery of Never Treated Populations: An Investigation using Results from Surveys across Six West African Countries - Diana Stukel

POSTER SESSION B

Convention Center - Hall I-1 (1st Floor) 75 - Poster Session B - 12:00 pm

LB-9207 - Neglected parasitic zoonoses and the importance of adopting aOne -Health approach for soil- transmitted helminth and schistosomiasis control in Ghana

LB-9243 - Sentinel-site monitoring of the prevalence and intensity of soil-transmitted helminthiasis and schistosomiasis in Rwanda: measuring needs to enhance control interventions

LB-9244 - A film about schistosomiasis as an intervention in Pemba Island, Tanzania

6725 - Accurate Detection of Female Genital Schistosomiasis - A Neglected Gynecological Tropical Disease

7501 - The Financial Impact of Livestock Schistosomiasis and Understanding the Importance of Policy Buy-in on Intervention Success

7140 - The impact of chronic schistosomiasis on co-infections with dengue virus in Madagascar

7434 - Integrated lymphatic filariasis, schistosomiasis and soil transmitted helminthiasis impact assessment in Ohaukwu, Ebonyi state, Nigeria

7459 - Evaluation of Soil-transmitted Helminthiasis and Schistosomiasis Coverage following Six Years of Mass Drug Administration in Five Nigeria States

7472 - Antibody-omics Reveals Biomarkers of Schistosomiasis and Cross-talk with Tuberculosis

7501 - The Financial Impact of Livestock Schistosomiasis and Understanding the Importance of Policy Buy-in on Intervention Success

7519 - Sensitivity of cluster, practical and sentinel impact assessment methodologies for adjusting preventive chemotherapy for schistosomiasis elimination in Nigeria

7521 - Using Human-Centered Design to support Development and Improvement of a Mobile Enabled Diagnostics for Schistosomiasis Control Analytics (MEDSCAN) Software for Schistosomiasis Diagnosis in Western Kenya

7523 - Multi-Contrast Machine Learning Improves Schistosomiasis Diagnostic Performance

7524 - Mapping Risks for Female Genital Schistosomiasis in Urban settings to Guide Public Health Interventions

7526 - Advancements in Schistosomiasis Diagnosis: Is Recombinant Antibody POC-CCA more reliable?

7531 - Community Awareness of Female Genital Schistosomiasis and Mass Drug Administration Participation in the Abobo District, Ethiopia - Findings from the FAST Package Pilot Project

7532 - Moving from district to sub-district schistosomiasis implementation in Senegal: time to change and adapt strategies

7533 - Predictors of Schistosomiasis Japonicum Infection Risk in Sichuan,China

7538 - The Colonial Impact On Schistosomiasis Research, Present Day Inequalities And Moving Towards An Equitable Research Environment

 

 

Saturday, Nov 16

113 - Innovative Tools for the Control of NTDs. How to Achieve Impact through Access Beyond Drug Donations

Convention Center - Room 357 (3rd Floor) 8AM

  • 8:30 AM Pediatric praziquantel. Insights from a pivotal trial for the treatment of schistosomiasis - Maurice Odiere
  • 9:00 AM Panel discussion with donors and stakeholders on the access of new tools for the control of NTDs - Julie Jacobson; Emily Wainwright; Carol Karutu; Christy Hanson; Hayato Urabe

POSTER SESSION C

Convention Center - Hall I-1 (1st Floor) - 120 - Poster Session C 11:00 AM

8217- Understanding perceptions of schistosomiasis and its control among highly endemic lakeshore communities in Mayuge; Uganda

8252 - Biomarker discovery and assay development to detect antibodies to Schistosoma haematobium

8255 - Female Genital Schistosomiasis (FGS) Knowledge Gaps and Needs in Sub-Saharan Africa: Analysis and Review of Action Plans Generated from a Peer-to-Peer Education Method

8258 - The impact of extreme rainfall events on schistosomiasis transmission in communities living around Manombo Special Reserve, Madagascar

8261- Community preferences for interventions to reduce human to snail transmission of schistosomiasis in Mayuge district Uganda

8262 - Unravelling the True Impact of Schistosomiasis: Redefining the WHO Elimination as a Public Health Problem Target

8266 - DNA methylation profiles in urothelial bladder cancer tissues and children with schistosomiasis from Eggua, Ogun State Nigeria

8267 - Deep Humoral Profiling Coupled with Machine Learning Reveals Novel Diagnostic and Morbidity Biomarkers for Schistosomiasis Pathophysiology

8269 - Schistosomiasis japonicum infection in the Philippines: Low Prevalence among children aged 1-4 years and correlation between Helminth Burden and Intestine Inflammation

8271 - Trogocytosis: a potent mechanism for host resistance to schistosomiasis

8273 - Community and Individual Preferences For A New Water Infrastructure For Non-Drinking Activities In A Schistosomiasis Endemic Area

 


143 - Schistosomiasis I: Immunology, Pathology, Molecular Biology, Diagnostics and Treatment

Convention Center - Room 354/355 (3rd Floor) 3PM

  • 3:00 PM 8330 - A clinical score to screen children in need for chronic fascioliasis testing in Cusco - Peru - Karen Mozo Velazco
  • 3:15 PM 8331 - Diagnostic accuracy of colposcopy for female genital schistosomiasis screening at primary level of care - Pia Rausche
  • 3:30 PM 8332 - Transcriptomics of the African freshwater snail vector Biomphalaria sudanica s.l. reveals candidate loci for schistosome resistance - Tom Pennance
  • 3:45 PM 8333 - Automated diagnosis of Schistosoma haematobium with artificial intelligence on handheld digital microscopes in rural Côte d’Ivoire - María Díaz de León Derby*
  • 4:00 PM 8334 - Characterization and Process Development of a Schistosoma haematobium Serine Protease Inhibitor (Shserpin-p46): A Next Generation Vaccine for Urogenital Schistosomiasis - Adebayo Molehin
  • 4:15 PM 7531 - Community Awareness of Female Genital Schistosomiasis and Mass Drug Administration Participation in the Abobo District, Ethiopia - Findings from the FAST Package Pilot Project - Claudia Duguay
  • 4:30 PM 8336 - EMPOWER: Enrichment Metagenomic Profiling for Women’s Reproductive Health - Jennifer Fitzpatrick

8336 - EMPOWER: Enrichment Metagenomic Profiling for Women’s Reproductive Health 

Convention Center - Room 354/355 (3rd Floor) 4:30 PM


159 - Revolutionizing Healthcare: The Impact of Artificial Intelligence on Neglected Tropical Diseases

Convention Center - Room 383/384/385 (3rd Floor) - 5:15 PM

  • 5:25 PM Using artificial intelligence-based digital pathology for the detection of soil-transmitted helminths and intestinal schistosomiasis - Peter Ward

 

 

Sunday, Nov 17

170 - American Committee of Molecular Cellular and Immunoparasitology (ACMCIP): Parasite Vaccine Development

Convention Center - Room 354/355 (3rd Floor) 8:00 AM

  • 9:15 AM - A Phase I/II Study of the Safety, Immunogenicity, and Efficacy of Sm-TSP-2/Alhydrogel with or without AP 10-701 for Intestinal Schistosomiasis in Healthy Ugandan Adults - Chrispus Bakunda

177 - Schistosomiasis II: Epidemiology and Control

 Convention Center - Room 395/396 (3rd Floor) 8AM

  • 8:00 AM 8406 - Combining wearable GPS loggers with environmental and snail data to uncover fine-scale Schistosoma mansoni transmission dynamics in Uganda - Fabian Reitzug
  • 8:15 AM 8407 - Acceptability and feasibility of a one-stop home-based genital self-sampling for Female Genital Schistosomiasis, Human Papilloma Virus and Trichomonas and HIV self-testing: Baseline data from A longitudinal cohort study in Zambia - Rhoda Ndubani
  • 8:30 AM 8408 - Schistosoma mansoni and Helicobacter pylori Co-infections among School-Aged Populations: A Study in Nigerian Communities - Babatunde Adewale
  • 8:45 AM 8409 - Main Results from a Phase II Randomised Placebo-Controlled Trial of Praziquantel in Preschool Children with Intestinal Schistosomiasis - Amaya Bustinduy
  • 9:00 AM 8410 - The Use of Water eDNA in Snail Identification for the Understanding of Fasciola Environmental Burden and Snail Diversity in the Highlands of Peru - Melinda Tanabe
  • 9:15 AM 8411 - Inflammation-adjusted vitamin A deficiency is associated with heavy Schistosoma mansoni infection intensity among preschool-aged children in Uganda - Susannah Colt
  • 9:30 AM 8412 - Association of S. haematobium Infection with Pregnancy in Tanzania - Sheridan Bowers

185 - The Challenge of Schistosomiasis Diagnosis and Treatment in Young Children and Pregnant Women – The Example of freeBILy

Convention Center - Room 356 (3rd Floor)

  • 11:40 AM Introduction and Purpose of the Session - Andrea Kreidenweiss
  • 11:45 AM Introduction and Purpose of the Session - Daniela Fusco
  • 11:50 AM The diagnostic challenges of schistosomiasis: why do we need a POC? - Pytsje Hoekstra
  • 12:00 PM Lessons learned from the field - Evaluation of the performance of circulating anodic antigen(CAA) measurement as a diagnostic tool for the detection of Schistosoma haematobium infections in pregnant women and their newborn and child in Lambaréné, Gabon - Yabo Josiane Honkpehedji
  • 12:20 PM Lessons learned from the field - Schistosomiasis among pregnant women in rural Madagascar: a call for action for adapting public health strategies - Raphael Rakotozandrindrainy
  • 12:30 PM Lessons learned from the field - Evaluation of the performance of the point of care circulating cathodic antigen (POC-CCA) measurement as a diagnostic tool for the detection of Schistosoma mansoni infections in pregnant women in rural Madagascar - Rivonirina Andry Rakotoarivelo
  • 12:40 PM Modelling the cost-effectiveness of test and treat strategies for schistosomiasis - Elisa Sicuri

 

Research